|
#
|
Concept name
|
Type
|
Relation
|
Support
|
Score
|
|
1
|
BCL2 gene
|
Gene
|
Known
|
Explain
|
0.13344
|
|
2
|
CASP3 gene
|
Gene
|
Inferred
|
Explain
|
0.09798
|
|
3
|
BCL2L1 gene
|
Gene
|
Known
|
Explain
|
0.07353
|
|
4
|
CASP9 gene
|
Gene
|
Inferred
|
Explain
|
0.05372
|
|
5
|
CYCS gene
|
Gene
|
Inferred
|
Explain
|
0.04687
|
|
6
|
nuclear fragmentation during apoptosis
|
Function
|
Known
|
Explain
|
0.04229
|
|
7
|
release of matrix enzymes from mitochondria
|
Function
|
Known
|
Explain
|
0.03883
|
|
8
|
polysaccharide peptide
|
Compound
|
Known
|
Explain
|
0.03769
|
|
9
|
Quinacrine
|
Compound
|
Known
|
Explain
|
0.03703
|
|
10
|
BAK1 gene
|
Gene
|
Known
|
Explain
|
0.03663
|
|
11
|
cis-bis(3-aminoflavone)dichloroplatinum(II)
|
Compound
|
Known
|
Explain
|
0.03656
|
|
12
|
BID gene
|
Gene
|
Known
|
Explain
|
0.03543
|
|
13
|
xanthoangelol
|
Compound
|
Known
|
Explain
|
0.03539
|
|
14
|
4-amino-1,8-naphthalimide
|
Compound
|
Known
|
Explain
|
0.03536
|
|
15
|
Aminacrine
|
Compound
|
Known
|
Explain
|
0.03523
|
|
16
|
phytosphingosine
|
Compound
|
Known
|
Explain
|
0.03487
|
|
17
|
3,4,5,4'-tetramethoxystilbene
|
Compound
|
Known
|
Explain
|
0.03453
|
|
18
|
establishment or maintenance of transmembrane electrochemical gradient
|
Function
|
Known
|
Explain
|
0.03432
|
|
19
|
cleavage of lamin
|
Function
|
Known
|
Explain
|
0.03405
|
|
20
|
N,N-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide
|
Compound
|
Known
|
Explain
|
0.03392
|
|
21
|
apoptotic mitochondrial changes
|
Function
|
Known
|
Explain
|
0.03353
|
|
22
|
1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline
|
Compound
|
Known
|
Explain
|
0.03328
|
|
23
|
PARP1 gene
|
Gene
|
Inferred
|
Explain
|
0.03324
|
|
24
|
tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex
|
Compound
|
Known
|
Explain
|
0.03293
|
|
25
|
(1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane
|
Compound
|
Known
|
Explain
|
0.03238
|
|
26
|
hyperoside
|
Compound
|
Known
|
Explain
|
0.03217
|
|
27
|
MCL1 gene
|
Gene
|
Known
|
Explain
|
0.03181
|
|
28
|
grifolin
|
Compound
|
Known
|
Explain
|
0.03102
|
|
29
|
BH3 domain binding
|
Function
|
Known
|
Explain
|
0.03092
|
|
30
|
acetyl-aspartyl-glutamyl-valyl-aspartal
|
Compound
|
Known
|
Explain
|
0.03081
|
|
31
|
GW8510
|
Compound
|
Known
|
Explain
|
0.03081
|
|
32
|
mitochondrial permeability transition pore complex
|
Component
|
Known
|
Explain
|
0.03066
|
|
33
|
Scutellaria barbata extract
|
Compound
|
Known
|
Explain
|
0.03056
|
|
34
|
Apitoxin
|
Compound
|
Known
|
Explain
|
0.03010
|
|
35
|
dideoxypetrosynol A
|
Compound
|
Known
|
Explain
|
0.02993
|
|
36
|
transformed cell apoptosis
|
Function
|
Known
|
Explain
|
0.02988
|
|
37
|
mitochondrial fragmentation during apoptosis
|
Function
|
Known
|
Explain
|
0.02956
|
|
38
|
regulation of protein heterodimerization activity
|
Function
|
Known
|
Explain
|
0.02946
|
|
39
|
2-amino-4-hydroxy-6-formylpteridine
|
Compound
|
Known
|
Explain
|
0.02921
|
|
40
|
Vindesine
|
Compound
|
Known
|
Explain
|
0.02913
|
|
41
|
BCL2-like apoptosis inhibitor
|
Domain
|
Known
|
Explain
|
0.02905
|
|
42
|
4,5,6,7-tetrabromobenzotriazole
|
Compound
|
Known
|
Explain
|
0.02894
|
|
43
|
diazene
|
Compound
|
Known
|
Explain
|
0.02888
|
|
44
|
gallium nitrate
|
Compound
|
Known
|
Explain
|
0.02883
|
|
45
|
tripchlorolide
|
Compound
|
Known
|
Explain
|
0.02865
|
|
46
|
N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugate
|
Compound
|
Known
|
Explain
|
0.02848
|
|
47
|
Acridine Orange
|
Compound
|
Known
|
Explain
|
0.02847
|
|
48
|
PK 11195
|
Compound
|
Known
|
Explain
|
0.02843
|
|
49
|
7-hydroxycoumarin
|
Compound
|
Known
|
Explain
|
0.02834
|
|
50
|
AN 215
|
Compound
|
Known
|
Explain
|
0.02833
|
|
51
|
periodate-oxidized adenosine
|
Compound
|
Known
|
Explain
|
0.02817
|
|
52
|
IPR020726
|
Domain
|
Known
|
Explain
|
0.02779
|
|
53
|
Cantharides
|
Organism
|
Known
|
Explain
|
0.02774
|
|
54
|
mafosfamide
|
Compound
|
Known
|
Explain
|
0.02771
|
|
55
|
IDN 5109
|
Compound
|
Known
|
Explain
|
0.02722
|
|
56
|
Apoptosis regulator Bcl-2, BH
|
Domain
|
Known
|
Explain
|
0.02721
|
|
57
|
echinocystic acid
|
Compound
|
Known
|
Explain
|
0.02711
|
|
58
|
codonoposide
|
Compound
|
Known
|
Explain
|
0.02711
|
|
59
|
benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone
|
Compound
|
Known
|
Explain
|
0.02710
|
|
60
|
Epothilones
|
Compound
|
Known
|
Explain
|
0.02684
|
|
61
|
fraxetin
|
Compound
|
Known
|
Explain
|
0.02647
|
|
62
|
IPR020717
|
Domain
|
Known
|
Explain
|
0.02643
|
|
63
|
S-(1,2-dichlorovinyl)cysteine
|
Compound
|
Known
|
Explain
|
0.02639
|
|
64
|
chan su
|
Compound
|
Known
|
Explain
|
0.02638
|
|
65
|
gamboge acid
|
Compound
|
Known
|
Explain
|
0.02625
|
|
66
|
B cell apoptosis
|
Function
|
Known
|
Explain
|
0.02622
|
|
67
|
Amifostine
|
Compound
|
Known
|
Explain
|
0.02619
|
|
68
|
BAY 43-9006
|
Compound
|
Known
|
Explain
|
0.02618
|
|
69
|
shogaol
|
Compound
|
Known
|
Explain
|
0.02591
|
|
70
|
Buserelin
|
Compound
|
Known
|
Explain
|
0.02583
|
|
71
|
beta-solamarine
|
Compound
|
Known
|
Explain
|
0.02571
|
|
72
|
Ytterbium
|
Compound
|
Known
|
Explain
|
0.02535
|
|
73
|
beta Sitosterol
|
Compound
|
Known
|
Explain
|
0.02516
|
|
74
|
Lymphoma, T-Cell, Cutaneous
|
Disease
|
Known
|
Explain
|
0.02494
|
|
75
|
ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate
|
Compound
|
Known
|
Explain
|
0.02492
|
|
76
|
IPR020728
|
Domain
|
Known
|
Explain
|
0.02485
|
|
77
|
honokiol
|
Compound
|
Known
|
Explain
|
0.02479
|
|
78
|
SK-7041
|
Compound
|
Known
|
Explain
|
0.02478
|
|
79
|
hesperetin
|
Compound
|
Known
|
Explain
|
0.02453
|
|
80
|
D 21266
|
Compound
|
Known
|
Explain
|
0.02448
|
|
81
|
Asbestos, Amosite
|
Compound
|
Known
|
Explain
|
0.02429
|
|
82
|
carboxycinnamic acid bishydroxamide
|
Compound
|
Known
|
Explain
|
0.02428
|
|
83
|
malvidin chloride
|
Compound
|
Known
|
Explain
|
0.02414
|
|
84
|
2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone
|
Compound
|
Known
|
Explain
|
0.02413
|
|
85
|
induction of retinal programmed cell death
|
Function
|
Known
|
Explain
|
0.02404
|
|
86
|
theaflavin
|
Compound
|
Known
|
Explain
|
0.02402
|
|
87
|
CASP8 gene
|
Gene
|
Inferred
|
Explain
|
0.02382
|
|
88
|
2,4-thiazolidinedione
|
Compound
|
Known
|
Explain
|
0.02298
|
|
89
|
activation of caspase activity by cytochrome c
|
Function
|
Known
|
Explain
|
0.02294
|
|
90
|
ellipticine
|
Compound
|
Known
|
Explain
|
0.02196
|
|
91
|
mono-(2-ethylhexyl)phthalate
|
Compound
|
Known
|
Explain
|
0.02164
|
|
92
|
LAQ824
|
Compound
|
Known
|
Explain
|
0.02154
|
|
93
|
Caryolysine
|
Compound
|
Known
|
Explain
|
0.02130
|
|
94
|
ursolic acid
|
Compound
|
Known
|
Explain
|
0.02124
|
|
95
|
esculetin
|
Compound
|
Known
|
Explain
|
0.02114
|
|
96
|
Doxazosin Mesylate
|
Compound
|
Known
|
Explain
|
0.02113
|
|
97
|
AGN 190168
|
Compound
|
Known
|
Explain
|
0.02110
|
|
98
|
delphinidin
|
Compound
|
Known
|
Explain
|
0.02102
|
|
99
|
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole
|
Compound
|
Known
|
Explain
|
0.02078
|
|
100
|
Leuprolide
|
Compound
|
Known
|
Explain
|
0.02052
|